The identification of tuberculosis biomarkers in human urine samples

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1719-1729

  Young, Brandy L ^a   Mlamla, Zandile ^b   Gqamana, Putuma P ^c   Smit, Salome ^d   Roberts, Teri ^e   Peter, Jonathan ^f   Theron, Grant ^f   Govender, Ureshnie ^f   Dheda, Keertan ^a,f   Blackburn, Jonathan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; BIOLOGICAL MARKER; CADHERIN; CALBINDIN; CUBILIN; CYSTATHIONINE GAMMA LYASE; DESMOPLAKIN; DEXTRO ALANINE DEXTRO ALANINE LIGASE; DNA DIRECTED RNA POLYMERASE; DNA HELICASE; FATTY ACID BINDING PROTEIN; GANGLIOSIDE GM2 ACTIVATOR PROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN VI; IMMUNOGLOBULIN KAPPA CHAIN; INVOLUCRIN; LIPOCORTIN 5; MEMBRANE PROTEIN; NITRATE REDUCTASE; OXIDOREDUCTASE; POLYKETIDE SYNTHASE; PRION PROTEIN; PROLINE RICH PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RETINA S ANTIGEN; SYNDECAN 1; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; DISEASE MARKER; ENRICHMENT CULTURE; FEMALE; GENE ONTOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; POINT OF CARE TESTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; URINALYSIS; HOSPITAL INFORMATION SYSTEM; LATENT TUBERCULOSIS; LIQUID CHROMATOGRAPHY; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SOUTH AFRICA; TUBERCULOSIS; URINE;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POINT-OF-CARE SYSTEMS; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; TUBERCULOSIS; URINALYSIS;

EID: 84901839581     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00175113     Document Type: Article

References (29)

1. World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test: Technical and Operational 'How-to' Practical Considerations. Geneva, WHO Press, 2011.
2. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184: 132-140.
3. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
4. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 45-55.
5. Peter J, Green C, Hoelscher M, et al. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 2010; 16: 262-270.
6. Pai M, Minion J, Steingart K, et al. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16: 271-284.
7. Dheda K, Ruhwald M, Theron G, et al. Point-of-care diagnosis of tuberculosis: past, present and future. Respirology 2013; 18: 217-232.
8. Minion J, Leung E, Talbot E, et al. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J 2011; 38: 1398-1405.
9. Peter JG, Theron G, van Zyl-Smit R, et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012; 40: 1211-1220.
10. Wheelock CE, Goss VM, Balgoma D, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-825.
11. Rosenkrands I, Weldingh K, Jacobsen S, et al. Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis 2000; 21: 935-948. (Pubitemid 30194073)
12. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006; 368: 1012-1021. (Pubitemid 44353670)
13. Kashino SS, Pollock N, Napolitano DR, et al. Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules. Clin Exp Immunol 2008; 153: 56-62. (Pubitemid 351809340)
14. Pollock NR, Macovei L, Kanunfre K, et al. Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis. J Clin Microbiol 2013; 5: 1367-1373.
15. Mehaffy MC, Kruh-Garcia NA, Dobos KM. Prospective on Mycobacterium tuberculosis proteomics. J Proteome Res 2012; 11: 17-25.
16. Zhang L, Lowrie D, Zhou H. Proteomic progress in studying tuberculosis from 2010 to 2011. J Biophys Chem 2011; 2: 395-400.
17. Nesvizhskii AI, Aebersold R. Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics 2005; 4: 1419-1440. (Pubitemid 41555469)
18. Martens L, Vandekerckhove J, Gevaert K. DBToolkit: processing protein databases for peptide-centric proteomics. Bioinformatics 2005; 21: 3584-3585. (Pubitemid 41236010)
19. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
20. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
21. Klahr S, ed. Atlas of Diseases of the Kidney Volume Four. Systemic Diseases and the Kidney. Hoboken, Wiley, 1999.
22. Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 2011; 10: 637-645.
23. Adachi J, Kumar C, Zhang Y, et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006; 7: R80.
24. Baena A, Porcelli SA. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2009; 74: 189-204.
25. Seth M, Lamont EA, Janagama HK, et al. Biomarker discovery in subclinical mycobacterial infections of cattle. PLoS One 2009; 4: e5478.
26. Tanaka T, Sakurada S, Kano K, et al. Identification of tuberculosis-associated proteins in whole blood supernatant. BMC Infect Dis 2011; 11: 71.
27. Lyman SD, Escobar S, Rousseau a M, et al. Identification of CD7 as a cognate of the human K12 (SECTM1) protein. J Biol Chem 2000; 275: 3431-3437. (Pubitemid 30083050)
28. Tumani H, Reiber H, Nau R, et al. Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis. Neurosci Lett 1998; 242: 5-8. (Pubitemid 28122695)
29. Diel R, Loddenkemper R, Zellweger JP, et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785-801.